Molly M.Wilkens

Associate

Minneapolis + 1.612.217.8923

Molly Wilkens is an experienced antitrust attorney, focusing her practice on mergers; acquisitions; government investigations by federal, state, and international agencies; and antitrust litigation.

Molly has represented a variety of clients before the U.S. Department of Justice, Federal Trade Commission, state, and international antitrust enforcers. She has extensive experience in a range of industries, including health care (providers and payers), pharmaceuticals, medical devices, telecommunications, tobacco, and food products.

Her transactional work encompasses counseling clients at every stage of a deal from premerger planning through regulatory filings, investigations, merger challenge litigation, as well as post-closing investigations. She has been involved in some of the most significant transactions to recently come before the antitrust agencies, including successfully defending against the Federal Trade Commission's attempt to block STERIS Corporation's acquisition of Synergy Health as well as Cabell Huntington Hospital's acquisition of St. Mary's Medical Center.

Molly also has experience in complex litigation, including negotiating and managing e-discovery, briefing and motion practice, preparing and defending fact witnesses for depositions, and trial preparation.

Molly maintains an active pro bono practice. She has successfully represented unaccompanied minor children in obtaining Special Immigrant Juvenile Status and recently first-chaired an immigration trial in which she obtained asylum on behalf of a mother and her four children.

Molly is a member of the State Bar of California, the Antitrust Practice Group of the American Health Lawyers Association, and the American Bar Association, Antitrust Section.

Experience

  • Cabell cleared to acquire St. Mary's following dismissal of FTC antitrust lawsuit to block transactionAfter a nearly two-year fight with the U.S. Federal Trade Commission, Cabell Huntington Hospital, Inc. has overcome all regulatory hurdles to its acquisition of St. Mary’s Medical Center, Inc., clearing the way to combine Huntington, West Virginia’s only two health systems.
  • Reynolds American acquired by British American Tobacco Plc in deal valued at $49 billionJones Day advised Reynolds American Inc. ("RAI") regarding the acquisition by British American Tobacco, p.l.c. ("BAT") of 57.8 percent of the outstanding shares of RAI not owned by BAT and its affiliates in a transaction valued at $49 billion.
  • Asylum granted to Guatemalan mother and her four childrenJones Day client A.P. and her four children escaped Guatemala in 2015, fleeing gang violence and domestic violence.
  • Sutter Health defends antitrust suitsJones Day represents Sutter Health in two antitrust suits brought by putative classes alleging that Sutter has conspired to violate the state and federal antitrust laws with respect to Sutter's provision of health care services in Northern California.
  • Atmel acquired by Microchip Technology for $3.56 billionJones Day advised Atmel Corporation (NASDAQ: ATML) on its sale to Microchip Technology Incorporated (NASDAQ: MCHP) in a cash (85 percent) and stock (15 percent) transaction valued at approximately $3.56 billion.
  • Atmel receives unsolicited superior proposal and terminates definitive agreement to be acquired by Dialog for $4.6 billionJones Day represented Atmel Corporation in connection with its definitive agreement to be acquired by UK-based Dialog Semiconductor plc in a cash and stock transaction for $4.6 billion.
  • Reynolds American sells Natural American Spirit International businesses to JT Group for $5 billionJones Day advised Reynolds American Inc. in its $5 billion sale of the international rights to the Natural American Spirit brand name and associated trademarks, along with the international companies that distribute and market the brand outside the U.S., to the Japan Tobacco Group of companies (JT Group).
  • STERIS defeats FTC's attempt to block Synergy Health acquisition on antitrust groundsIn a rare litigation defeat against the Federal Trade Commission, Ohio based STERIS Corporation prevailed against an antitrust challenge brought in federal court by the FTC, which sought to block STERIS's proposed $1.9 billion acquisition of Synergy Health plc.
  • CommScope acquires TE Connectivity's network business for $3 billionJones Day acted as worldwide antitrust counsel to CommScope Holding Company, Inc., a global network infrastructure and connectivity provider based in North Carolina, on its $3 billion acquisition of the Telecom, Enterprise and Wireless business of Switzerland-based electronics company TE Connectivity Ltd.
  • DIRECTV merger with AT&T receives antitrust clearanceJones Day represented California based satellite TV provider DIRECTV on the antitrust aspects of its $67 billion acquisition by AT&T, a deal that combines AT&T's terrestrial internet and video business with DIRECTV's satellite video business.
  • Reynolds American acquires Lorillard for $27.4 billionJones Day advised Reynolds American Inc. (NYSE: RAI) in its acquisition of Lorillard, Inc. for $27.4 billion and in the related $7.1 billion divestiture to an affiliate of Imperial Tobacco Group and $4.7 billion investment by British American Tobacco, RAI's largest shareholder.
  • Hitachi Data Systems acquires PentahoJones Day advised Hitachi Data Systems Corporation in its acquisition of Pentaho Corporation, a leading big data integration and business analytics company with an open source-based platform for diverse big data deployments.
  • Texas Industries secures antitrust clearance for $2.7 billion merger with Martin Marietta MaterialsJones Day assisted Texas Industries, Inc. in securing antitrust clearance from the U.S. Department of Justice for its $2.7 billion acquisition by Martin Marietta Materials, Inc.
  • SAP acquires FieldglassJones Day advised SAP AG in the acquisition of Fieldglass, Inc., the leading technology provider for procuring and managing contingent labor and services.
  • Aetna wins dismissal of antitrust litigationJones Day won dismissal of an antitrust case brought by four diagnostic testing laboratories alleging that Aetna Inc. and other healthcare payers had entered unlawful exclusive dealing arrangements with Quest Diagnostics.
  • Certain Hostess bread brands and bakeries acquired by Flowers Foods for $355 millionJones Day advised Hostess Brands, Inc. regarding the sale of its Wonder, Merita, Nature's Pride, Home Pride, and Butternut bread brands and associated bakeries to Flowers Foods, Inc. for $355 million.
  • Hostess sells Hostess and Dolly Madison snack cake business to Apollo Global Management and Metropoulos & Co. for $410 millionJones Day advised Hostess Brands, Inc. regarding the stalking horse bid by affiliates of Apollo Global Management, LLC and Metropoulos & Co. in the purchase for the majority of the assets of the snack cake business, including both Hostess® and Dolly Madison® branded products, including the iconic Twinkies® brand for $410 million.
  • SAP acquires leading cloud-based business commerce network Ariba for $4.3 billionJones Day advised SAP AG in its $4.3 billion acquisition of Ariba, Inc.
  • Eastman Chemical acquires Solutia for $4.8 billionJones Day advised Eastman Chemical Company, a global chemical company that manufactures and sells a broad portfolio of chemicals, plastics, and fibers, in its $4.8 billion acquisition and related $3.5 billion financing of Solutia Inc., a global leader in performance materials and specialty chemicals.
  • ACI Worldwide acquires S1 for $520 millionJones Day advised ACI Worldwide, Inc. ("ACI") in connection with its agreement to acquire S1 Corporation ("S1") for approximately $520 million.
  • Speaking Engagements

    • March 10, 2015
      What You Absolutely Positively Must Know About HSR
    • May 2012
      Women in IP Networking Happy Hour
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.